The syndrome of inappropriate antidiuretic hormone (SI-ADH) was first described in 1957 by Schwartz and colleagues in two lung cancer cases that showed urinary sodium loss (1). SIADH is characterised by hyponatraemia, inappropriately increased urine osmolality, increased urine sodium, and decreased serum osmolality in a euvolemic patient without edema. Also, these findings should be considered in a patient with normal cardiac, renal, adrenal, hepatic, and thyroid functions and taking no diuretics. Excess water is the main problem in SIADH and therefore dilutional hyponatraemia develops (2).
bilateral breath sounds, and no rales and rhonchi were heard. Heart sounds were normal except for mild tachycardia (102/ minute). Examination of the abdomen revealed vesicular lesions extending from the umbilicus to the waist on a single dermatome zone and some of the lesions were resolving. She had hypoactive bowel sounds. There was no hepatosplenomegaly, peripheral lymphadenopathy, or pretibial edema. Laboratory investigations on admission were as follows: BUN, 24 mg/dL; creatinine, 1.0 mg /dL; AST, 17 U/L; ALT, 18 U/L; Na, 112 mmol/L; and K, 4.1 mmol/L. Other biochemical parameters were normal. Hepatitis markers and anti-HIV serology were negative. Thyroid function tests, ECG, and echocardiography were performed for the etiology of euvolemic hyponatraemia and these were all normal. ADH measurement cannot be performed in our hospital, so serum ADH level was not measured.
The patient was normotensive and hyperkalaemia and hypoglycaemia were not observed, so adrenal insufficiency was excluded. She was euvolemic and did not use a diuretic drug or combination. The patient's serum sodium concentration was 112 mmol/L (135-145 mmol/L), serum osmolarity was 238 mOsm/L (275-295 mOsm/L), urine sodium concentration was 55 mmol/L (<20 mmol/L), and urine osmolality was 452 mosm/kg, so she was diagnosed as SIADH. Other conditions that may lead to SIADH such as lung cancer and cranial pathologies were excluded by chest radiography and cranial tomography. Sodium deficit was calculated as 885 mEq. After administiration of 250 cc 3% saline infusion in 5 hours, the symptoms of vomiting, weakness, and dizzines disappeared. After limitation of water and interruption of drugs, serum Na concentration rose to 137 mmol/L in 72 hours and the patient was diagnosed as SIADH due to codeine usage.
DISCUSSION
Codeine is a natural derivative of opium alkaloids. Besides its relatively weak analgesic effect, it is used as an antitussive and antidiarrhoeal drug. It is a less effective analgesic than the other non-steroidal drugs, tramadol, and even paracetamol (5). It exerts its analgesic effect by its conversion to morphine and morphine-6-glucuronide in the liver. Codeine is bioactivated to morphine and morphine-6-glucuronide by the hepatic cytochrome P4502D6 (CYP2D6). Therefore, as an analgesic, the efficacy and safety of codeine are very closely related to CYP2D6 polymorphism. It is known that codeine has lower activity in patients who are CYP2D6 poor metabolisers but the toxicity risk of morphine is higher in patients who metabolise ultrafast (6) .
SIADH is a syndrome characterised by low serum sodium level, low serum osmolality, high urine osmolality, and high urine sodium in the situation that arginine-vasopressin secretion from the posterior pituitary must be blocked but continues. There are many reasons for SIADH but the pathophysiology of the arginine-vasopressin secretion cannot be elucidated in the majority of SIADH patients due to drug use (7). In our patient, we observed codeine-induced SIADH, which is rarely encountered.
SIADH can be caused by a variety of drugs, particularly carbamazepine, selective seratonin reuptake inhibitors (SSRIs), and phenothiazines. Many cases and clinical investigations have documanted that SSRIs can significantly cause hyponatraemia. Opioids act centrally via µ receptors, providing moderate to severe pain relief. Opioids also inhibit the reuptake of neurotransmitters, such as noradrenaline (norepinephrine) and serotonin most prominently. Based on this information, Udy and colleagues presented a case of tramadol-induced hyponatraemia after unicompartmental knee replacement surgery (8) .
It is known that all opioids exert their effects by interacting with µ opioid receptors involved in the pain warning of the central nervous system, which are located both presynaptically and postsynaptically (9) . As a result of stimulation of the presynaptic µ receptors, the release of γ-amino butyric acid (GABA), an inhibitor neurotransmitter, is inhibited and inhibition of the dopamine pathways is increased (10) . It is known that GABA is the major inhibitor neurotransmitter in the central nervous system and also in the hypothalamic neural axis. Therefore, as a result of stimulation of presynaptic µ receptors by morphine, the secretion of inhibitor neurotransmitter GABA is blocked and arginine-vasopressin secretion increases. Also, codeine may inhibit the reuptake of serotonin and noradrenaline-like SSRIs. We think that in our patient, arginine-vasopressin secretion might have been increased by such mechanisms and so SIADH developed. Our patient was treated by 3% saline infusion, fluid restriction, and discontinuation of drug therapy and her serum sodium returned to normal levels on the third day. We know that pain caused by shingles may increase AVP secretion from the pituitary gland or its effect at the collecting duct, which then cause hyponatraemia itself. However, the patient's pain persisted even when her sodium was normalised and discontinuation of her medication is the major therapeutic argument. Thus, we do not think the pain caused by herpes zoster was the cause of SIADH. As a result, clinicians should measure serum electrolytes intermittently in order to avoid missing the diagnosis of SIADH in patients using opioid analgesics.
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